Psychedelic therapy has been gaining not only popularity but acceptance in the medical community in recent years.
Exploring the companies and themes that make up this emerging and exciting new sector
Psychedelic Drug Stocks Then-And-Now: Six Months Ago Versus Today
Psychedelic stocks are well off of their 2020 highs. But they are even further from their 2020 lows. Opportunity knocks.
NYU launching $10M Center for Psychedelic Medicine in Manhattan
New York University wants to expand our minds — but in a trippy new way.
Mind Cure Announces Addition of Global Technology Leader Robert C. Hill to Board of Directors
MINDCURE's new Director is a veteran of capital markets.
Why Is Everyone So Obsessed With Mushrooms Right Now?
It used to be that the only time I really saw mushrooms was when a few white button mushrooms appeared on a garden salad or atop my cheese pizza.
MINDCURE’s Psychedelics R&D Targets Blockbuster TBI Treatment Market
MINDCURE's R&D on traumatic brain injury (TBI) targets the LARGEST individual market for psychedelic drugs.
Mindset Pharma Added to North American Psychedelics Index
Toronto, Ontario-- Mindset Pharma Inc., a drug discovery and development company focused on developing next generation psilocybin-inspired medicines and related technologies, is pleased to announce that effective today, it has been added to the North American Psychedelics Index which is provided by German-based index provider, Solactive.
Vermont Lawmakers Prepare Psychedelics And Broader Drug Decriminalization Bills For Introduction
Vermont lawmakers plan to introduce at least two bills this legislative session to decriminalize the possession of drugs, with one of those proposals expected early next week.
MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine Company
MindMed enhances its mental health platform with the acquisition of a machine-learning digital medicine company.
Can LSD cure our pandemic anxiety? MindMed is spending big to find out
While many people will look back on the pandemic as a dark time, it has also spurred some positive developments—most notably in the field of drug development, where miraculous breakthroughs like mRNA vaccines are transforming immunology.
MINDCURE Announces Official Release of Nootropic and Adaptogen Products, Available on E-Commerce Platform
MINDCURE's first line of mushroom-based nootropics now available for sale.
California bill would decriminalize psychedelics, paving the way for medical treatment
A California lawmaker has introduced legislation that would decriminalize psychedelics in the state, the latest bold step in a movement to end America’s war on drugs.